Skip to content

Author

Shruti Srivastava

We have 2 of 48 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Serum Complement Component 4A and Neurofilament Light Chain Levels Before and After Risperidone Monotherapy in Patients With Psychosis.

The preliminary findings of the study suggest that risperidone monotherapy resulted in a significant reduction in serum C4A levels, whereas serum NfL levels did not change and remained elevated in patients with psychosis, and risperidone monotherapy resulted in a significant improvement in quality of life.

Rakesh R. Biradar, Rachna Gupta, Shruti Srivastava et al. · 0 citations
Open access Sep 2026

LC-MS/MS Method for Simultaneous Quantification of Zolpidem, Zopiclone, and Their Metabolites in Human Urine and Its Pharmacokinetic Application.

The method's potential for retrospective urinary screening of Z-drug exposure in forensic and clinical toxicology is supported, and its potential for retrospective urinary screening of Z-drug exposure in forensic and clinical toxicology is supported.

Varsha Chauhan, Manu Sharma, Murtada Taha et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.